Viatris Inc.: all 777 studies

Page 4 of 8. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.

• Observational Study to Evaluate the Actual Use and Effectiveness of Dymista® Nasal Spray in Asian PatientsCompletedNCT05158972
• Study to Evaluate the Effectiveness of Legalon®CompletedNCT05051527
• Abacavir, Dolutegravir and Lamivudine Dispersible Tablets (60 mg/5 mg/30 mg)CompletedNCT05030025Early Phase 1
• The Effect of Severe Kidney Impairment on Cenerimod PharmacokineticsCompletedNCT05004311Phase 1
• Observation of the Effects of Guideline-driven Lifestyle Interventions, Including Use of a Red-yeast Based NutraceuticalCompletedNCT05000541
• Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic DermatitisCompletedNCT04976868
• A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of CenerimodCompletedNCT04819464Phase 1
• A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy SubjectsCompletedNCT04557280Phase 1
• The Effect of Reduced Liver Function on Selatogrel PharmacokineticsCompletedNCT04406896Phase 1
• A Bioequivalence Study of Sildenafil Citrate Orally-Disintegrating Film Dosage FormWithdrawnNCT04391868Phase 1
• To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cenerimod on the Use of Oral Contraceptives in Women. To Study the Effect That Charcoal Has on the Elimination of Cenerimod From the Body, in Women and Men.CompletedNCT04255277Phase 1
• An Bioequivalence Study Comparing Nicergoline 10 mg Tablet Manufactured in China With Nicergoline 10 mg Tablet Manufactured in Italy Under Fasted and Fed Conditions in Healthy Chinese ParticipantsCompletedNCT04176367Phase 1
• Post-marketing Surveillance (PMS) to Observe the Safety and Effectiveness of Lyrica CR Extended Release TabletsStatus unknownNCT04171453
• Single Oral Dose of 4 mg Cenerimod in Healthy Japanese and Caucasian SubjectsCompletedNCT04052360Phase 1
• A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy SubjectsCompletedNCT03814200Phase 1
• Relative Bioavailability Study of Zoloft Oral Solution to Zoloft TabletsCompletedNCT03711708Phase 4
• DYmista NAsal Spray in CHInese PatientsCompletedNCT03599791Phase 3
• A Study to Evaluate ACT-246475 Fate in Healthy Male SubjectsCompletedNCT03593278Phase 1
• A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy SubjectsCompletedNCT03430661Phase 1
• Revatio Special Investigation for Long-term Use in Pediatric PatientsCompletedNCT03364244
• A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the BodyCompletedNCT03173625Phase 1
• MP-AzeFlu Allergen Chamber - Onset of Action StudyCompletedNCT03004131Phase 4
• A Study to Evaluate Cenerimod in Healthy Male SubjectsCompletedNCT02914223Phase 1
• PROs in Chronic Cervical Pain Patients With Accompanying Upper Limb Radiating Pain Treated With PregabalinCompletedNCT02868359
• Thorough QT (TQT) Study of TD-4208 in Healthy SubjectsCompletedNCT02820311Phase 1
• TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male SubjectsCompletedNCT02772159Phase 1
• Bioavailability Study of Pregabalin Extended Release Formulation With Various Release Rates in Healthy VolunteersCompletedNCT02725112Phase 1
• MYL-1401A Efficacy and Safety Comparability Study to Humira®CompletedNCT02714322Phase 3
• Study to Evaluate The Effect Of Sertraline on the Cardiac Repolarization in Healthy SubjectsCompletedNCT02651623Phase 1
• A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult SubjectsCompletedNCT02637193Phase 1
• Phase 1 Study of Trastuzumab Administered as a Single Intravenous InfusionCompletedNCT02594761Phase 1
• Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic ImpairmentCompletedNCT02581592Phase 1
• REVIparin-BRIDging-in a General Practice Setting in GErmanyTerminatedNCT02579122
• Pharmacokinetics of TD-4208 in Patients With Severe Renal ImpairmentCompletedNCT02578082Phase 1
• Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed NeulastaCompletedNCT02479646Phase 1
• Clinical Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactions of ACT-334441TerminatedNCT02479204Phase 1
• An Open Study to Assess the Robustness of the CRC749 InhalerCompletedNCT02474017Phase 1
• Adalimumab PK Bioequivalence Study to EU and US Sourced HumiraCompletedNCT02472912Phase 1
• Phase I - Pharmacokinetic Comparability Study in Healthy Male VolunteersCompletedNCT02469987Phase 1
• Efficacy and Safety Study With MYL-1401H and NeulastaCompletedNCT02467868Phase 3
• Observational Study in Cystic Fibrosis Patients Using TOBI® PODHALER® or Other FDA Approved Inhaled Antipseudomonal Antibacterial DrugsCompletedNCT02449031
• Bioequivalence Study to Assess Systemic Exposure of FP and SAL FDC From Different DPIsCompletedNCT02215122Phase 1
• A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female VolunteersCompletedNCT02109185Phase 1
• Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral SumatriptanCompletedNCT01989936Phase 3
• Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and PlaceboCompletedNCT01986270Phase 3
• Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack StudyCompletedNCT01986088Phase 3
• Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute MigraineCompletedNCT01978496Phase 3
• Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With SildenafilNo longer availableNCT01897740
• Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose StudyCompletedNCT01859481Phase 3
• Patient Reported Outcomes in Pulmonary Arterial HypertensionWithdrawnNCT01792622
• Bioequivalence Study For Orally-Disintegrating Tablet Of SildenafilCompletedNCT01737203Phase 1
• Bioequivalence Of Zoloft ODT To Jzoloft In Healthy Japanese SubjectsCompletedNCT01699724Phase 1
• Food Effect Study For New FormulationCompletedNCT01656798Phase 1
• An Open Label Access Study For Subjects Who Completed A1481156No longer availableNCT01582438
• Pharmacokinetics and Relative Bioavailability StudyCompletedNCT01521767Phase 1
• A 12-Week Study in Adult Subjects With AsthmaCompletedNCT01516086Phase 2
• 12-Week Study in Adult Subjects With AsthmaCompletedNCT01516073Phase 2
• Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)CompletedNCT01453179Phase 4
• A 5-treatment, Study in Healthy Volunteers to Assess The Safety, Tolerability, and Pharmacokinetics of Four Controlled Release (CR) Pregabalin Tablet Formulations and the Immediate Release (IR) Formulation Administered FastedCompletedNCT01443169Phase 1
• Bioequivalence Study of Doxazosin 4 Mg Orally-Disintegrating Tablet With Or Without Water To Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted ConditionCompletedNCT01389609Phase 1
• A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular HypertensionCompletedNCT01379144Phase 2
• A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT01368445Phase 3
• IV Sildenafil Persistent Pulmonary Hypertension Of The NewbornWithdrawnNCT01360671Phase 2
• An Investigation of the Effects of Erythromycin on the Pharmacokinetics of the Pregabalin Controlled Release TabletCompletedNCT01342198Phase 1
• Tepilta® Versus Oxetacaine, Antacids and PlaceboTerminatedNCT01336530Phase 3
• An Bioequivalence Study Of Xanax Extended Release Tablets From Two Different Manufacturing SitesCompletedNCT01330472Phase 1
• A Bioequivalence Study Of A New Alprazolam Dropped Formulation Versus Alprazolam TabletsCompletedNCT01322867Phase 4
• Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted In The Evening or Immediately Following A 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy VolunteersCompletedNCT01321671Phase 1
• Primary Care Identification Of Patients With Chronic Neuropathic Low Back Pain StudyWithdrawnNCT01298466Phase 4
• Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted At Bedtime Or Immediately Following A 400-500 or 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy VolunteersCompletedNCT01291524Phase 1
• Bioequivalence of a New and a Commercial Alprazolam Sublingual FormulationWithdrawnNCT01285505Phase 1
• Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND StudyTerminatedNCT01280747
• An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following Various Sized Lunches As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy VolunteersCompletedNCT01270815Phase 1
• An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following A Low, Medium, And High-Fat Evening Meal As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy VolunteersCompletedNCT01257529Phase 1
• An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy VolunteersCompletedNCT01257516Phase 1
• Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional TabletCompletedNCT01256151Phase 1
• Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Versus To Viagra® Oral Tablet.CompletedNCT01254383Phase 1
• A Pivotal Bioequivalence Study Between The Sildenafil Powder For Oral Suspension (10 Mg/Ml) And The Sildenafil 10 Mg Immediate Release (IR) Tablet Relative To The Revatio 20 Mg IR Tablet In Healthy Volunteers Under Fasting ConditionsCompletedNCT01247805Phase 1
• Africa and Middle East Cardiovascular Epidemiological StudyCompletedNCT01243138
• An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy VolunteersCompletedNCT01220219Phase 1
• Real World Data Study Assessing The Persistency Of Xalacom And The Other Fixed Dose Combination Products, Duotrav And Ganfort, In The United KingdomCompletedNCT01206361
• An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin CapsuleCompletedNCT01202435Phase 1
• An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin CapsuleCompletedNCT01202422Phase 1
• Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal SpraysCompletedNCT01194622Phase 1
• Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal SpraysCompletedNCT01190852Phase 1
• Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mgCompletedNCT01184391Phase 1
• Fed Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mgCompletedNCT01183676Phase 1
• A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01168310Phase 2
• Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)WithdrawnNCT01124877Phase 3
• Bioequivalence Study Of PHENYTOIN Suspension Made By Pfizer, Versus EPAMIN® Made By McNeil LA LLC In Healthy Volunteers Under Fasting ConditionsCompletedNCT01122953Phase 1
• Bioequivalence Study Of Phenytoin Suspension Versus Epamin® In 34 Healthy Volunteers.CompletedNCT01122940Phase 1
• Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)WithdrawnNCT01117220Phase 3
• A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT01113593Phase 2
• A Study Of The Evaluation Of Patients Opulation With Erectile Dysfunction, Treated With SildenafilCompletedNCT01108900
• A Study To Assess The Pharmacokinetics, Safety, And Tolerability Of A Pregabalin Controlled Release Formulation Administered Following Various Sized Caloric Meals As Compared To The Pregabalin Immediate Release FormulationCompletedNCT01080612Phase 1
• Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With LipitorCompletedNCT01078285
• 12-Week Efficacy And Safety Of Pregabalin In Treating Restless Legs Syndrome (RLS) SubjectsWithdrawnNCT01061372Phase 3
• A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting ConditionsWithdrawnNCT01046162Phase 1
• Bioequivalence of a New Sublingual and a Reference Alprazolam Immediate Release Tablet FormulationWithdrawnNCT01027689Phase 1
• A Relative Bioavailability Study of Revatio for the Crushed Tablets, Extemporaneously Prepared Formulation, and the Intact Tablets at 20 mg Dose in Healthy VolunteersCompletedNCT01027117Phase 1

← Viatris Inc. overview and focus areas